Allscripts Healthcare Solutions (MDRX) Now Covered by Evercore ISI

Research analysts at Evercore ISI started coverage on shares of Allscripts Healthcare Solutions (NASDAQ:MDRX) in a research note issued to investors on Thursday. The firm set a $17.50 price target on the software maker’s stock. Evercore ISI’s target price points to a potential upside of 15.97% from the stock’s current price.

Other analysts have also recently issued research reports about the stock. Citigroup began coverage on shares of Allscripts Healthcare Solutions in a research note on Thursday, January 4th. They issued a “buy” rating on the stock. Robert W. Baird reissued a “buy” rating and issued a $16.00 target price on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 17th. SunTrust Banks cut shares of Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday. They noted that the move was a valuation call. KeyCorp reissued a “hold” rating on shares of Allscripts Healthcare Solutions in a research note on Friday, October 27th. Finally, Dougherty & Co reissued a “buy” rating and issued a $16.00 target price (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a research note on Tuesday, October 3rd. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and eleven have issued a buy rating to the company. Allscripts Healthcare Solutions presently has a consensus rating of “Hold” and a consensus price target of $15.66.

Allscripts Healthcare Solutions (NASDAQ MDRX) traded down $0.21 during trading hours on Thursday, hitting $15.09. 1,105,164 shares of the stock traded hands, compared to its average volume of 1,966,991. Allscripts Healthcare Solutions has a one year low of $11.01 and a one year high of $16.13. The company has a debt-to-equity ratio of 1.20, a quick ratio of 0.98 and a current ratio of 0.98. The company has a market cap of $2,750.00, a P/E ratio of -13.01, a price-to-earnings-growth ratio of 2.16 and a beta of 1.32.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings data on Thursday, November 2nd. The software maker reported $0.12 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.12. Allscripts Healthcare Solutions had a negative net margin of 12.23% and a positive return on equity of 6.53%. research analysts forecast that Allscripts Healthcare Solutions will post 0.46 EPS for the current fiscal year.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $14.26, for a total value of $213,900.00. Following the transaction, the president now directly owns 1,351,773 shares in the company, valued at $19,276,282.98. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $14.35, for a total transaction of $71,750.00. Following the completion of the transaction, the executive vice president now owns 191,607 shares in the company, valued at $2,749,560.45. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 56,796 shares of company stock worth $804,842. Company insiders own 0.75% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in MDRX. Vanguard Group Inc. lifted its position in shares of Allscripts Healthcare Solutions by 1.2% during the second quarter. Vanguard Group Inc. now owns 14,824,640 shares of the software maker’s stock worth $189,162,000 after purchasing an additional 181,721 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Allscripts Healthcare Solutions by 3.7% during the third quarter. Dimensional Fund Advisors LP now owns 9,508,667 shares of the software maker’s stock worth $135,308,000 after purchasing an additional 337,382 shares in the last quarter. State Street Corp lifted its position in shares of Allscripts Healthcare Solutions by 28.6% during the second quarter. State Street Corp now owns 5,975,551 shares of the software maker’s stock worth $76,251,000 after purchasing an additional 1,330,721 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its position in shares of Allscripts Healthcare Solutions by 1.0% during the third quarter. Fuller & Thaler Asset Management Inc. now owns 5,062,035 shares of the software maker’s stock worth $72,033,000 after purchasing an additional 49,823 shares in the last quarter. Finally, Neuberger Berman Group LLC lifted its position in shares of Allscripts Healthcare Solutions by 5.5% during the third quarter. Neuberger Berman Group LLC now owns 3,676,088 shares of the software maker’s stock worth $52,311,000 after purchasing an additional 190,158 shares in the last quarter.

ILLEGAL ACTIVITY NOTICE: “Allscripts Healthcare Solutions (MDRX) Now Covered by Evercore ISI” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/18/allscripts-healthcare-solutions-mdrx-now-covered-by-evercore-isi.html.

Allscripts Healthcare Solutions Company Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Analyst Recommendations for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply